REVELATION BIOSCIENCES, INC. (REVB) has 5 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 18, 2026 filed Aug. 17, 2026 | Chawla Lakhmir S Director | $0 | 32,011 | +263% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 17, 2026 | Rolke James Chief Executive Officer | $0 | 208,076 | +97% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 17, 2026 | ROPER JESS Director | $0 | 32,011 | +250% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 17, 2026 | Zygmont Chester Stanley III Chief Financial Officer | — | +208,073 | +226% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 17, 2026 | CARVER JENNIFER Director | $0 | 32,011 | +251% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free